4//SEC Filing
FINKELSTEIN J J 4
Accession 0000914190-18-000296
CIK 0000707511other
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 5:12 PM ET
Size
6.0 KB
Accession
0000914190-18-000296
Insider Transaction Report
Form 4
FINKELSTEIN J J
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2018-07-17$0.21/sh+250,000$52,500→ 250,000 totalExercise: $0.21Exp: 2028-07-17→ Common Stock (250,000 underlying)
Holdings
- 1,637,991
Common Stock
Footnotes (1)
- [F1]The option vests in four equal installments of 62,500 shares on each of July 17, 2018, 2019, 2020 and 2021.
Documents
Issuer
REGENERX BIOPHARMACEUTICALS INC
CIK 0000707511
Entity typeother
Related Parties
1- filerCIK 0001125610
Filing Metadata
- Form type
- 4
- Filed
- Jul 18, 8:00 PM ET
- Accepted
- Jul 19, 5:12 PM ET
- Size
- 6.0 KB